Clinical Trials outside U.S.: Severe Coronary Artery Disease

SEVERAL CLINICAL TRIALS targeting heart disease have shown that adult stem cell therapy is safe and effective. Adult stem cell therapy for heart disease is commercially available on at least five continents at last count. The most well known of these companies is TheraVitae, a private company based in Bangkok, Thailand, with locations in Kiryat Weiz—mann, Israel; Toronto, Canada; Singapore; Taipei, Taiwan; and Hong Kong. TheraVitae is a private, multinational company focused on using stem cells from the patient's own blood in order to treat a variety of disorders, especially cardiovascular diseases. Research, development, and manufacturing are performed at the company's state—of-the—art cell therapy facility located in Kiryat Weizmann. TheraVitae's plans treatments for optical and neurological diseases in the future.

The company has already developed a ...